Vanguard Group Inc Forma Therapeutics Holdings, Inc. Transaction History

Vanguard Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$7.12 - $20.24 $1.57 Million - $4.45 Million	220,012 Added 13.37%	1,865,281 $37.2 Million
Q2 2022 Aug 12, 2022	SELL	$5.1 - $10.0 $3.13 Million - $6.13 Million	-613,487 Reduced 27.16%	1,645,269 $11.3 Million
Q1 2022 May 13, 2022	SELL	$8.34 - $14.69 $5.02 Million - $8.84 Million	-601,897 Reduced 21.04%	2,258,756 $21 Million
Q4 2021 Feb 14, 2022	BUY	$13.6 - $24.89 $921,468 - $1.69 Million	67,755 Added 2.43%	2,860,653 $40.7 Million
Q3 2021 Nov 12, 2021	BUY	$21.22 - $25.7 $10.5 Million - $12.8 Million	497,048 Added 21.65%	2,792,898 $64.8 Million

Q2 2021 Aug 13, 2021	BUY	$22.86 - $30.95 $52.5 Million - $71.1 Million	2,295,850 New	2,295,850 $57.1 Million

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.